• Users Online: 35
  • Print this page
  • Email this page
Year : 2017  |  Volume : 4  |  Issue : 1  |  Page : 67-81

Nanocarrier mediated intracellular delivery of neutralizing antibodies for the management of abrin lethality

Department of Biochemistry, Indian Institute of Science, Bangalore – 560012, India

Correspondence Address:
Anjali A Karande
Department of Biochemistry, Indian Institute of Science, Bangalore – 560012
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2349-3666.240592

Rights and Permissions

Abrin is a highly lethal ribosome-inactivating protein of high relevance in bio-warfare. Neutralizing antibodies to abrin reported so far afford protection in a very small window with no rescue observed post-abrin exposure. The utility of the most specific mode of defense against abrin poisoning is thus undermined. We proposed that intracellular delivery of antibodies which otherwise lack the ability to enter cells would increase the therapeutic potential. Towards this, we analyzed the use of silica nanoparticles and chimeric Sesbania mosaic virus-like particles in delivering antibodies inside cells. The antibody-nanocarrier conjugate was found to be effective in protecting cells from abrin-mediated toxicity when administered as long as 9 h prior and up to 1 h post abrin exposure. These results highlight the potential of nanocarrier-based intracellular delivery of neutralizing antibodies in widening the therapeutic window for prophylaxis and to some extent post-exposure treatment of abrin poisoning.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded127    
    Comments [Add]    

Recommend this journal